Timothy F Cloughesy

53PUBLICATIONS
483CO-AUTHORS
Biological adaptationPredictive and prognostic markersPharmacogenomicsHaematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Apr 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Patrick Y Wen, Donald A Berry, Meredith B Buxton

|Mar 16, 2026
Framework for Statistical Parametric Mapping of the Interactions between Glioblastoma Location, Treatment, Prognostic Variables, and Survival Using a Phase III Trial.

Francesco Sanvito, Catalina Raymond, Donatello Telesca

|Oct 28, 2025
Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma.

Anna F Piotrowski, Kent Shih, Pierre Giglio

|Aug 22, 2025
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastoma.

James R Whittle, Maria Vieito, Kristoffer Rohrberg

|Aug 19, 2025
Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Patrick Y Wen, Michael Weller, Eudocia Q Lee

|Jul 22, 2025
The use of minor response, volumetric assessment, and growth rate kinetics as endpoints in grade 1-3 glioma clinical trials: a RANO perspective.

Martin J van den Bent, Timothy F Cloughesy, Benjamin M Ellingson

Pageof 9

Frequent Collaborators

22 joint publications

Benjamin M Ellingson

13 joint publications

Phioanh Nghiemphu

13 joint publications

Linda M Liau

12 joint publications

Patrick Y Wen